The creatine kinase energy transport system in the failing mouse heart

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 6, 2007, Pages 1129-1136

  Lygate, Craig A ^a   Fischer, Alexandra ^a   Sebag Montefiore, Liam ^a   Wallis, Julie ^a   ten Hove, Michiel ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Creatine transporter; Heart failure; Hypertrophy; Metabolism

Indexed keywords

CREATINE KINASE; CREATINE KINASE BB; CREATINE KINASE MB; CREATINE KINASE MM; MITOCHONDRIAL CREATINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENERGY TRANSFER; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART FAILURE; HEART STRESS; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CREATINE KINASE; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEART FAILURE, CONGESTIVE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM;

ANIMALIA; MUS; VASCONCELLEA CANDICANS;

EID: 34249707953     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.03.899     Document Type: Article

References (39)

1. Wyss M., and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80 3 (2000) 1107-1213
2. Ventura-Clapier R., Garnier A., and Veksler V. Energy metabolism in heart failure. J. Physiol. 555 Pt. 1 (2004) 1-13
3. Schlattner U., Tokarska-Schlattner M., and Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 1762 2 (2006) 164-180
4. ten Hove M., Lygate C.A., Fischer A., Schneider J.E., Sang A.E., Hulbert K., et al. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 111 19 (2005) 2477-2485
5. Saupe K.W., Spindler M., Tian R., and Ingwall J.S. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ. Res. 82 8 (1998) 898-907
6. Nahrendorf M., Spindler M., Hu K., Bauer L., Ritter O., Nordbeck P., et al. Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovasc. Res. 65 2 (2005) 419-427
7. Kaasik A., Veksler V., Boehm E., Novotova M., Minajeva A., and Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ. Res. 89 2 (2001) 153-159
8. Tian R., Christe M.E., Spindler M., Hopkins J.C., Halow J.M., Camacho S.A., et al. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J. Clin. Invest. 99 4 (1997) 745-751
9. Horn M., Remkes H., Stromer H., Dienesch C., and Neubauer S. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 104 15 (2001) 1844-1849
10. Spindler M., Engelhardt S., Niebler R., Wagner H., Hein L., Lohse M.J., et al. Alterations in the myocardial creatine kinase system precede the development of contractile dysfunction in beta(1)-adrenergic receptor transgenic mice. J. Mol. Cell. Cardiol. 35 4 (2003) 389-397
11. Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 7 (1997) 2190-2196
12. Hugel S., Horn M., de Groot M., Remkes H., Dienesch C., Hu K., et al. Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. Am. J. Physiol. 277 6 Pt. 2 (1999) H2167-H2175
13. Ingwall J.S., and Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95 2 (2004) 135-145
14. Morrow D.A., and Givertz M.M. Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular disease. Circulation 112 21 (2005) 3218-3221
15. Taegtmeyer H. Cardiac metabolism as a target for the treatment of heart failure. Circulation 110 8 (2004) 894-896
16. Stanley W.C., Recchia F.A., and Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85 3 (2005) 1093-1129
17. Lygate C.A., Hulbert K., Monfared M., Cole M.A., Clarke K., and Neubauer S. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. Cardiovasc. Res. 58 3 (2003) 632-637
18. Pfeffer M.A., Pfeffer J.M., Steinberg C., and Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72 2 (1985) 406-412
19. Patten R.D., Aronovitz M.J., Einstein M., Lambert M., Pandian N.G., Mendelsohn M.E., et al. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin. Sci. (Lond.) 104 2 (2003) 109-118
20. Rockman H.A., Ross R.S., Harris A.N., Knowlton K.U., Steinhelper M.E., Field L.J., et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 88 18 (1991) 8277-8281
21. Lygate C.A., Schneider J.E., Hulbert K., Ten Hove M., Sebag-Montefiore L.M., Cassidy P.J., et al. Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res. Cardiol. 101 1 (2006) 8-16
22. Neubauer S., Horn M., Naumann A., Tian R., Hu K., Laser M., et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J. Clin. Invest. 95 3 (1995) 1092-1100
23. Tian R., Nascimben L., Kaddurah-Daouk R., and Ingwall J.S. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J. Mol. Cell. Cardiol. 28 4 (1996) 755-765
24. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270 1 (1999) 41-49
25. Dawson D., Lygate C.A., Saunders J., Schneider J.E., Ye X., Hulbert K., et al. Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice. Circulation 110 12 (2004) 1632-1637
26. Laser A., Ingwall J.S., Tian R., Reis I., Hu K., Gaudron P., et al. Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction. J. Mol. Cell. Cardiol. 28 7 (1996) 1531-1538
27. Neubauer S., Frank M., Hu K., Remkes H., Laser A., Horn M., et al. Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J. Mol. Cell. Cardiol. 30 4 (1998) 803-810
28. Nascimben L., Friedrich J., Liao R., Pauletto P., Pessina A.C., and Ingwall J.S. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 91 6 (1995) 1824-1833
29. Liao R., Nascimben L., Friedrich J., Gwathmey J.K., and Ingwall J.S. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ. Res. 78 5 (1996) 893-902
30. Ye Y., Gong G., Ochiai K., Liu J., and Zhang J. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation 103 11 (2001) 1570-1576
31. Shen W., Spindler M., Higgins M.A., Jin N., Gill R.M., Bloem L.J., et al. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. J. Mol. Cell. Cardiol. 39 3 (2005) 537-544
32. Nascimben L., Ingwall J.S., Pauletto P., Friedrich J., Gwathmey J.K., Saks V., et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 94 8 (1996) 1894-1901
33. Shen W., Asai K., Uechi M., Mathier M.A., Shannon R.P., Vatner S.F., et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100 20 (1999) 2113-2118
34. Wallis J., Lygate C.A., Fischer A., ten Hove M., Schneider J.E., Sebag-Montefiore L., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 112 20 (2005) 3131-3139
35. Ten Hove M., Chan S., Lygate C., Monfared M., Boehm E., Hulbert K., et al. Mechanisms of creatine depletion in chronically failing rat heart. J. Mol. Cell. Cardiol. 38 2 (2005) 309-313
36. Dobson G.P. On being the right size: heart design, mitochondrial efficiency and lifespan potential. Clin. Exp. Pharmacol. Physiol. 30 8 (2003) 590-597
37. Boehm E., Chan S., Monfared M., Wallimann T., Clarke K., and Neubauer S. Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine. Am. J. Physiol.: Endocrinol. Metab. 284 2 (2003) E399-E406
38. Takaoka H., Esposito G., Mao L., Suga H., and Rockman H.A. Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy. Am. J. Physiol.: Heart Circ. Physiol. 282 6 (2002) H2190-H2197
39. Miller D.D., and Walsh R.A. In vivo phosphorus-31 NMR spectroscopy of abnormal myocardial high-energy phosphate metabolism during cardiac stress in hypertensive-hypertrophied non-human primates. Int. J. Card. Imaging 6 1 (1990) 57-70